Haemodynamic response to intravenous hydralazine in patients with pulmonary hypertension (Q36747471)

16 August 2017

Haemodynamic response to intravenous hydralazine in patients with pulmonary hypertension (English)

1 reference

16 August 2017

1 reference

1 reference

McGoon MD

1

1 reference

16 August 2017

Seward JB

2

1 reference

16 August 2017

Vlietstra RE

3

1 reference

16 August 2017

Choo MH

4

1 reference

16 August 2017

Moyer TP

5

1 reference

16 August 2017

Reeder GS

6

1 reference

16 August 2017

language of work or name

1 reference

1 December 1983

1 reference

16 August 2017

British Heart Journal

1 reference

16 August 2017

50

1 reference

16 August 2017

6

1 reference

16 August 2017

579-585

1 reference

Influence of prostaglandin synthesis inhibitors on pulmonary vasodilatory effects of hydralazine in dogs with hypoxic pulmonary vasoconstriction

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481463

Clinical and haemodynamic effects of diazoxide in primary pulmonary hypertension

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481463

Primary pulmonary hypertension: effects of nifedipine

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481463

Captopril as treatment for patients with pulmonary hypertension. Problem of variability in assessing chronic drug treatment

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481463

Effects of prostaglandin E1 on pulmonary circulation in patients with pulmonary hypertension

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481463

Effects of isosorbide dinitrate on pulmonary hypertension in chronic obstructive pulmonary disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481463

Verapamil and Pulmonary Hypertension

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481463

The effects of dopamine and isoproterenol on the pulmonary circulation

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481463

Diazoxide in treatment of primary pulmonary hypertension

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481463

Oral hydralazine therapy for primary pulmonary hypertension.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481463

Primary pulmonary hypertension in a child. Response to pharmacologic agents.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481463

Isoproterenol as a potential pulmonary vasodilator in primary pulmonary hypertension.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481463

Primary Pulmonary Hypertension Treated with Oral Phentolamine

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481463

Hemodynamics at rest and during exercise after oral hydralazine in patients with cor pulmonale.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481463

The effects of oral hydralazine on right ventricular end-diastolic pressure in patients with right ventricular failure.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481463

The role of hydralazine therapy for pulmonary arterial hypertension of unknown cause.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481463

Primary pulmonary hypertension favorable effect of isoproterenol

5 September 2018

1 reference

12 December 2020

Selective high-performance liquid chromatographic assays for hydralazine and its metabolites in plasma of man

1 reference

12 December 2020

Deleterious effects of hydralazine in patients with pulmonary hypertension

1 reference

12 December 2020

Primary pulmonary hypertension. I. Clinical and hemodynamic study

1 reference

12 December 2020

The hemodynamic effects of isoproterenol on pulmonary hypertension in man

1 reference

12 December 2020

Identifiers

DOI

10.1136/HRT.50.6.579

1 reference

16 August 2017

1 reference

16 August 2017

PubMed publication ID

6652000

1 reference